Article Text

PDF

Correction

Statistics from Altmetric.com

doi:10.1136/heartjnl-2014-306786corr1

Tietjens J, Teerlink JR. Serelaxin and acute heart failure. Heart 2016;102:95–9. In this review the latest set of competing interests were not included in the published version. They are as follows; JT has no competing interests. JRT has received research grants and consulting fees from Amgen, Bayer, Cytokinetics, Novartis, and Trevena.

View Abstract

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Review
    Jeremy Tietjens John R Teerlink